In re Lidoderm Antitrust Litigation

Case # 14-md-02521
Case Name In re Lidoderm Antitrust Litigation
Jurisdiction US District Court for N.D. CA
Summary

Defendant (Endo Pharmaceuticals) manufactures and retails a lidocaine patch 5% (used to treat complications from shingles) under the brand name Lidoderm.  Plaintiffs allege that Defendant paid a competitor not to produce a lower-priced generic version of this patch.  As a result of this payoff, Defendant was able to keep the price of the patches artificially high and consumers were forced to pay a higher price for the product than they would in a truly competitive market.
Final Approval Date 09/20/2018
Result
  1. Final Approval and Attorneys' Fees granted.
  2. The Court found Objector Sweeney's objection to be untimely but still considered it and overruled it.
  3. Objector Sweeney withdrew her appeal and waived her right to appeal in exchange for Class Counsel withdrawing its discovery requests (see documents attached below).
Dismissal of Last Appeal N/A
Attachments Docket Report.pdf
Third Consolidated Amended Complaint.pdf
Preliminary Approval Order.pdf
Final Approval Order.pdf
Order Granting Attorneys Fees.pdf
Added to Index
Last Updated

Objection of Pamela Sweeney

Objectors Pamela Sweeney
Signers Pamela Sweeney
Attorneys
Summary
  1. Attorneys' fees are excessive.

Class Counsel motioned for expedited discovery of Objector Sweeney, which was granted by the Court.
Attachments Objection of Pamela Sweeney.pdf
Motion for Expedited Discovery of Objector Sweeney.pdf
Order Granting Motion for Discovery of Objector Sweeney.pdf
Order Withdrawing Sweeney Appeal.pdf
Added to Index
Last Updated